Rosetta Omics

🚀 Pfizer Healthcare Hub France Demo Night!🚀 Over the past months, we had the privilege of being part of the 5th edition of the Pfizer Healthcare Hub France (PHHF) acceleration program, alongside an inspiring community of healthcare innovators. Building innovation in healthcare is not only about developing great science and technology. It is about understanding real clinical needs, learning from the people who work closest to patients, and building the right partnerships to turn innovation into impact. At Rosetta Omics, our ambition is to advance precision cancer care by combining multiomics and AI to better understand and predict how patients respond to anticancer therapies, helping physicians make more informed treatment decisions and supporting drug developers in bringing better therapies to the right patients. The PHHF journey has given us the opportunity to learn, challenge our thinking and exchange with experienced mentors and leaders from Pfizer and WILCO, while continuing to strengthen our path from scientific innovation toward patient impact. We are looking forward to celebrating this journey at the PHHF Demo Night on October 1st, meeting fellow entrepreneurs, healthcare professionals, researchers, investors and partners, and sharing what we are building at Rosetta Omics. 📍 Pfizer France headquarters, Paris 📅 October 1, 2026 – 6:30 PM If you are attending, I would be very happy to meet you there! 🎟️ Participation is free upon registration. Places are limited, so register here: https://lnkd.in/ePpSZfY4 On the agenda for this evening, hosted by Jérôme LELEU L'Oeil de la E-santé : ✅ An opening session focusing on the challenges of sovereign health innovation and the ambitions of the PHHF, featuring Reda Guiha (President of Pfizer France) and Eric Vaysset (CEO of WILCO). ✅ A roundtable discussion bringing together Maximilien Levesque (AQEMIA), Amelie Litrowski (Doctoome), Johanna Michielin (BioLabs France), and Professor Eric Vibert, MD, PhD, IKO, KOH (Greater Paris University Hospitals - AP-HP, Assistance Publique – Hôpitaux de Paris) to address a key question: "How can we bridge the gap between innovation, real-world practice, and patient impact to build the future of healthcare?" Special thanks to Luca Mollo Sabrina Lesage, PhD Coumert Amelie Joël Crouzet Amine SAIGHI, MD Marie-Pierre Boussuge Amele Seghaieré Pierre Moriconi Valentine Ghozlan #HealthTech #Biotech #ArtificialIntelligence #PHHF #PfizerHealthcareHubFrance #Innovation

🚀 𝐃𝐄𝐌𝐎 𝐍𝐈𝐆𝐇𝐓 𝐏𝐇𝐇𝐅 #𝟓 : 𝐋’𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐞𝐧 𝐬𝐚𝐧𝐭𝐞́ 𝐟𝐚𝐢𝐭 𝐬𝐚 𝐫𝐞𝐧𝐭𝐫𝐞́𝐞 ! Le 1er octobre, le Pfizer Healthcare Hub France réunira l’écosystème Healthcare pour clôturer sa 5ᵉ édition, portée par Pfizer en partenariat avec WILCO. Après 9 mois d’accélération et de double mentorat, place à une soirée pour décrypter les transformations de la santé, confronter les expériences et mettre en lumière l’impact du programme sur les startups. 🎙️ Au cœur de cette soirée, animée par Jérôme LELEU, Président d’Interaction Healthcare et fondateur de L'Oeil de la E-santé : ▪️ Reda Guiha, Président de Pfizer France, et Eric Vaysset, CEO de WILCO, croiseront leurs visions sur l’innovation souveraine en santé et les ambitions du PHHF. ▪️Eric Vibert, MD, PhD, IKO, KOH (AP-HP, Assistance Publique - Hôpitaux de Paris), Johanna Michielin (BioLabs France), Maximilien Levesque (AQEMIA) et Amelie Litrowski (Doctoome) réuniront leurs regards médical, scientifique et entrepreneurial autour d’une question clé : comment rapprocher innovation, terrain et impact patient pour construire la santé de demain ? ▪️ Startups et mentors de la promo #5 partageront leurs avancées, leurs déclics et le rôle du double mentorat Pfizer × WILCO dans leur trajectoire. 🥂 La soirée se prolongera autour du Village Startups & d’un cocktail networking, pour rencontrer les acteurs qui font avancer l’innovation en santé. 📅 1er octobre | 18h30 - Pfizer France, Paris 14ème 👉Inscriptions ouvertes ! Réservez votre place : https://luma.com/cdueyqw5

[J-23] 📣 J'aurai le plaisir d'animer la 5️⃣ᵉ édition de la "Demo Night" du Pfizer Healthcare Hub France, le programme d’accélération des acteurs innovants qui façonneront la santé de demain, le jeudi 1er octobre à 18h30 au siège de Pfizer France à Paris 💡 Dans 3 semaines, + de 200 acteurs de l'écosystème de la santé et de la healthtech, de la recherche, investisseurs, entrepreneurs de la E-santé et experts du secteur se retrouveront pour ce rendez-vous de l'innovation en santé dédié aux acteurs du "PHHF" que je suis depuis sa création en 2022 🎯 Le "Pfizer Healthcare Hub France", c'est quoi ? Organisé par Pfizer en partenariat avec WILCO, le PHHF accompagne pendant 9️⃣ mois des startups de la HealthTech grâce à un dispositif unique de double mentorat, dans le cadre d’une aventure entrepreneuriale et humaine au service des patients et des soignants 📋 Je vous partage le programme de cet événement que j'aurai le plaisir d'animer : ✅ Regards croisés de dirigeants : Conversation entre Reda Guiha, Président de Pfizer France, et Eric Vaysset, CEO de WILCO, sur les enjeux de l’innovation souveraine et la force du dispositif PHHF dans le secteur de la santé ✅ Une table-ronde avec les interventions du Pr Eric Vibert, MD, PhD, IKO, KOH de l'AP-HP, Assistance Publique - Hôpitaux de Paris, Johanna Michielin de BioLabs, Maximilien Levesque de AQEMIA et Amelie Litrowski de Doctoome qui partageront leurs retours d'expériences et leurs expertises médicale, scientifique et entrepreneuriale afin d'identifier les pistes pour rapprocher innovation, terrain et, in fine, l'impact pour les patients ✅ Bilan & retours d’expérience : Focus sur les transformations, les synergies et les avancées des startups de la promotion du PHHF - John Djaffar de Pictaderm, Dr Gabriel KO de BioKortex, Tanel Petelot de Emobot et Wahid Awad, Ph.D. MBA de Rosetta Omics, aux côtés de leurs mentors - Coumert Amelie et Mirella Laguerre Charpentier de Pfizer - et Arnaud Pelloquin de Wilco 🗣️ L'événement se terminera avec une conclusion avec Dr Luca Mollo, Vice-Président - Directeur Médical de Pfizer, ainsi qu'un cocktail et du networking autour d'un village de Startups Un grand merci au Dr Amine SAIGHI, MD, Medical Operations Director de Pfizer & Président du PHHF, Pierre Moriconi, Responsable communication corporate, et Valentine Ghozlan, Communication Manager de Wilco, et toute l'équipe d'organisation pour leur invitation et leur confiance ainsi qu'à Laetitia Hans, Responsable des activités E-santé, et Caroline Fouré, Directrice Scientifique, de Interaction Healthcare, pour leur accompagnement 🔗 Voici le lien d'inscription si vous souhaitez participer à l'événement : https://lnkd.in/e3eDMx2C

Watch our Founder & CEO Dr. Wahid Awad, Ph.D. MBA interview with the Universités Pharmaceutiques 2026 at STATION F, (in French) :) Also on youtube: https://lnkd.in/emYsTgCw This was broadcasted during the roundtable: “La ‘vraie vie’ des entrepreneurs”, where our CEO spoke alongside Arthur Delapalme, Paul Rinaudo, Hélène GUIMIOT (CNIL - Commission Nationale de l'Informatique et des Libertés ) and David Sainati (French Ministry of Health) with Stephane Tholander as moderator. Thanks for the video interview : Rami Mustakim & Antoine Santi (Mon Studio TV) And thank you Linda Nait et Emmanuelle BERREBI for the invitaiton and organization. #RosettaOmics #UniversitésPharmaceutiques2026 #PrecisionMedicine #MultiOmics #Oncology #CancerCare #HealthTech #Biotech #FrenchTech #HealthcareInnovation

Summer time with the Rosetta Omics team ☀️🧬 A few moments together at STATION F learning, building, growing, and enjoying the journey along the way. Building Rosetta Omics is not only about science, technology or AI. Above all, it is about people coming together around a shared purpose. Thank you Aurore Ducamp Jawad Alharake Kimiya Younesi Heddie BEN MARZOUK Sinem Asan Marwa MOHAMED Shona Park Emma FRANCOIS for your hard work, curiosity, dedication, and willingness to learn and contribute. Our mission is ambitious: to help empower physicians and drug developers with better tools to make precision cancer care a reality and ultimately bring more hope and more life to cancer patients. There is still a long road ahead, but meaningful things are never built alone. We learn together. We grow together. We build together. And we do it for something greater than ourselves. #RosettaOmics #TeamSpirit #PrecisionOncology #CancerResearch #Biotech #HealthTech #STATIONF

🔗 Rosetta Omics 🤝 Grenoble Ecole de Management 🚀 For the second year in row, we have the opportunity to partner with the Grenoble Ecole de Management Advanced Master in Biomedical Management. We are collaborating with two student groups from Grenoble Management school (GEM) working on two consulting missions for Rosetta Omics This partnership gives us the opportunity to train a new generation of biopharma professionals who are enthusiast about oncology precision medicen and identify potential good profiles for Rosetta’s growth needs. 🎓 As part of their program, the advanced master students take on real business challenges and provide us with research, analysis, and fresh perspectives. 💡 It's been a really positive experience for us. The eight students brought curiosity, solid insights, and a fresh angle to the topics we're exploring. 🎓Thank you both groups : Laurine Magnin Luna Chamas Reine Abdo Aziz Hizem Astrid Sampieri Júlia Toledo Bastos Maryam Tan Kenza Noui For your commitment and interest in Rosetta’s mission . And thank you to GEM leadership, tutors and professors especially Prof. Vittorio de Pedys, Guillaume Lebel, MSc, MBA, Nacim Haderbache & Nour Shorrab for making this collaboration possible. As part of their mission, they get to spend a day with us at Station F and enjoy the Italian delights of la Felecita! :) #GEM #GrenobleÉcoleDeManagement #RosettaOMICS #PrecisionMedicine #StudentCollaboration

Rosetta Omics at the Universités Pharmaceutiques 2026 📅 We are pleased to announce that Rosetta Omics will be participating in the Universités Pharmaceutiques 2026, taking place in Paris on July 7–8. 🚀 Our CEO & Founder, Dr. Wahid Awad, Ph.D. MBA will be speaking in the session “La ‘vraie vie’ des entrepreneurs”, alongside Arthur Delapalme (Codoc) and Paul Rinaudo (ADLIN), and moderated by Stephane Tholander. 💬 This session will take a candid look at the realities of building a healthtech company: the day-to-day challenges, regulatory complexity, strategic trade-offs, but also the resilience and conviction that drive healthcare innovation forward. It will also be part of a broader dialogue with key stakeholders from the healthcare ecosystem, including Hélène GUIMIOT (CNIL - Commission Nationale de l'Informatique et des Libertés ) and David Sainati (French Ministry of Health), focusing on the real-world conditions required to innovate in healthcare. 🧬 At Rosetta Omics, we believe that advancing precision oncology requires strong collaboration across the entire healthcare ecosystem, from regulators to clinicians, researchers, and innovators. These conversations are essential to shaping the future of cancer care in France and beyond. 📍 See you in Paris on July 7–8 #RosettaOmics #UniversitésPharmaceutiques2026 #PrecisionMedicine #MultiOmics #Oncology #CancerCare #HealthTech #Biotech #FrenchTech #HealthcareInnovation

Great discussion of our CEO Wahid Awad, Ph.D. MBA on Friday at VivaTech 10th edition in Paris during the roundtable on AI in healthcare, organized by Bpifrance and La French Care brilliantly moderated by monsieur Olivier Chabanon and titled: « IA, biologie et soins : les champions français changent d’échelle », the roundtable was in French 🇫🇷 Our CEO shared the stage with: Stéphanie Allassonniere professor and vice president Université Paris Cité & PR[AI]RIE-PSAI and • Albert Reynaud H Company A few key takeaways from our discussion: 🔹 France and Europe has world-class talent, research, and healthcare infrastructure to build global AI champions. 🔹 The challenge is no longer innovation, but scaling startups into global leaders supported by access to capital, data and simplified regulations. I spoke about Bpifrance support which is key for deeptech startups like Rosetta Omics 🔹 Public-private partnerships are essential to accelerate the translation of research into real impact for patients. I mentioned our partnerships with hospitals in France as well as sole programs like Pfizer healthcare hub France and golden tickets from big pharma such as Sanofi Servier Ipsen Amgen and Pfizer in partnership with BioLabs BioLabs France 🔹 Europe has a unique opportunity to lead in AI for health by combining scientific excellence, trusted data, and strong collaboration: our CEO spoke about the Horizon Europe programs and the EIC - European Innovation Council Pathfinder European Commission programs as great tools but still very limited and hard to get for small startups. At Rosetta Omics , we are proud to contribute to this ambition by leveraging AI and multiomics to advance precision oncology and improve outcomes for cancer patients. Thank you to Olivier Chabanon Bpifrance , La French Care , and all participants for this inspiring exchange. Medicen Paris Region Paris Saclay Cancer Cluster (PSCC) STATION F Agoranov UM6P GLOBAL HUBS - France France Biotech Choose Paris Region Région Ile de France WILCO WILCO Healthcare #VivaTech #AI #Healthcare #HealthTech #PrecisionMedicine #Oncology #LaFrenchCare #Bpifrance #RosettaOmics